Posted in

Homepage Feature

UF at the ASCO Annual Meeting 2021

Physicians and researchers from the University of Florida are participating in the virtual American Society of Clinical Oncology (ASCO) meeting held on June 4-8, 2021. The ASCO Annual Meeting is one of the largest gatherings of medical professionals in the world. It brings together more than 25,000 oncology professionals from…

UF at the AACR Annual Meeting 2021

Physicians and researchers from the University of Florida participated in the virtual American Association for Cancer Research Annual Meeting held on April 10-15, 2021. AACR is a premier event in cancer research. The AACR Annual Meeting program covers the latest discoveries across the spectrum of cancer research—from population science…

UF researchers developing new cancer immunotherapy drug

UF Health Cancer Center researchers Drs. Zhang, Zhou and Zheng Immunotherapy is a type of cancer treatment designed to boost the body’s natural defenses to fight the cancer. It uses substances either made by the body or in a laboratory to improve or restore immune system function, according to…

Remembering Joseph Simone, M.D.

Dr. Joseph V. Simone We are saddened to share the news that Joseph V. Simone, M.D., former UF Health Cancer Center director and pioneering clinical investigator, passed away January 21, 2021, at the age of 85.An internationally recognized leader in cancer care, research and education, Simone’s research led…

Novel CD33 Antibodies Unravel Localization, Biology, and Therapeutic Implications of CD33 Isoforms

Drs. Angel Sampson and Andria Doty recently teamed up with Dr. Jatinder Lamba in the department of pharmacotherapy and translational research in the UF College of Pharmacy, and Dr. Soheil Meshinchi at the Fred Hutchinson Cancer Research Center, University of Washington, in an effort to further understand the therapeutic relevance of various forms of the CD33 protein as it relates to the antibody-drug therapy. CD33 is expressed on malignant cancer cells in nearly all patients with acute myeloid leukemia (AML) and there has been a long-standing interest in the development of CD33-directed monoclonal antibodies for the treatment of AML.

Cancer in the Time of Coronavirus: The COVID-19 Vaccine

On Jan. 8, the Florida Cancer Control and Research Advisory Council (CCRAB), North Central Florida Cancer Control Collaborative (NCFCCC), and UF Health Cancer Center hosted Cancer in the Time of Coronavirus: The COVID-19 Vaccine webinar on Zoom. In this webinar, speakers Christopher Cogle, M.D., and…